Health
Oxford-AstraZeneca COVID-19 Vaccine To Be Tested On Children For First Time – HuffPost
The new mid-stage trial will determine whether the coronavirus shot is effective on people between the ages of six and 17.

(Reuters) – The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.
The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university.
Around 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said.
The two-dose Oxford/AstraZeneca…
-
General17 hours ago
Internal Revenue Service starts cutting 20,000 workers
-
Noosa News16 hours ago
Man killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News21 hours ago
’Lethal new opioids’ prompt Wide Bay pill testing call
-
General19 hours ago
UK PM talks US tariff response with Albanese and Meloni